Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 2, 2026

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

7.5K

Novel human interleukin-15 agonists.

Xiaoyun Zhu1, Warren D Marcus, Wenxin Xu

  • 1Altor BioScience Corporation, Miramar, FL 33025, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|August 28, 2009
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Nitazoxanide reverses pulmonary vascular remodeling in pulmonary hypertension by targeting the IMPA1-RAGE signaling axis" [Toxicology and Applied Pharmacology 507 (2026) 117657].

Toxicology and applied pharmacology·2026
Same author

Trivalent mRNA-LNP Vaccine Induces Robust Humoral and Cellular Immunity in Mice: Preclinical Evaluation for Porcine Enteric Coronaviruses.

International journal of nanomedicine·2026
Same author

High-level biosynthesis of gastrodin in engineered Escherichia coli.

Journal of biotechnology·2026
Same author

Effect of breaking up prolonged sitting with physical activity on executive function: a three-level meta-analysis.

The international journal of behavioral nutrition and physical activity·2026
Same author

Multimodal calcium coordination and transport mechanisms of cod bone-derived novel peptides DYGGEY and GESGEAGDR.

Food chemistry·2026
Same author

Decreased Specific Pavlovian-to-Instrumental Transfer Effect in Internet Gaming Disorder Following Short-Term Abstinence from Gaming.

Neuropsychobiology·2026
Same journal

Optineurin restrains IL-17-associated neuroinflammation in trigeminal ganglia to preserve sensory function after ocular HSV-1 infection.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

Crystal structure and immune single-cell atlas provide insights into the functional divergence of type I IFNs in fish.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

Complement C3 deficiency increases the effector and cytotoxic functions of NK cells and suppresses tumor growth.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

Increased Nur77 is disconnected from TCR affinity in insulin-specific Tregs.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

FTR85 negatively regulates type I IFN antiviral signaling pathway by promoting K48-linked polyubiquitination of IRF3.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

An MR1-specific nanobody capable of blocking MR1T cell activation.

Journal of immunology (Baltimore, Md. : 1950)·2026
See all related articles

Researchers engineered a superagonist form of Interleukin-15 (IL-15) with enhanced T cell and NK cell activation. This modified IL-15 shows promise for developing more effective cancer immunotherapies.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Interleukin-15 (IL-15) is crucial for T cell and NK cell immunity.
  • IL-15 signaling involves IL-15 receptor alpha-chain, IL-2/IL-15Rbeta, and common gamma-chains.
  • Understanding IL-15's functional regions is key for therapeutic development.

Purpose of the Study:

  • To identify functionally important regions of human IL-15.
  • To generate and characterize IL-15 muteins with altered activity.
  • To explore the potential of IL-15 superagonists in immunotherapy.

Main Methods:

  • Site-directed mutagenesis to create IL-15 muteins.
  • Cell proliferation assays to measure biological activity.
  • Binding studies to assess receptor interactions.

More Related Videos

Analysis of Human Natural Killer Cell Metabolism
09:03

Analysis of Human Natural Killer Cell Metabolism

Published on: June 22, 2020

6.6K
Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
09:57

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

1.7K

Related Experiment Videos

Last Updated: May 2, 2026

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

7.5K
Analysis of Human Natural Killer Cell Metabolism
09:03

Analysis of Human Natural Killer Cell Metabolism

Published on: June 22, 2020

6.6K
Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
09:57

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

1.7K
  • Western blotting to analyze signaling pathway activation (Jak1, Stat5 phosphorylation).

    • Main Results:

    • Substitution at position 72 (N72D) yielded a potent IL-15 superagonist.
    • The N72D mutein showed a 4-5 fold increase in activity via enhanced IL-15Rbeta binding.
    • Superagonist activity was specific to the human IL-15 receptor complex.
    • Enhanced phosphorylation of Jak1 and Stat5, and improved anti-apoptotic effects were observed.
    • IL-15N72D fusion proteins retained superagonist activity.

    Conclusions:

    • Amino acid substitutions, particularly N72D, can create human IL-15 superagonists.
    • IL-15N72D demonstrates enhanced potency and signaling through the human receptor.
    • Engineered IL-15 superagonists offer potential for novel immunotherapeutic agents.
    • IL-15 superagonist fusion proteins may improve tumor-specific immunotherapy efficacy.